Aspireo Reports Somatoprim Phase IIa Proof of Concept Results in Acromegaly

News   Apr 03, 2013

 
Aspireo Reports Somatoprim Phase IIa Proof of Concept Results in Acromegaly
 
 
 

RELATED ARTICLES

Novel Method for Testing Vaccine Safety

News

Scientists from the Institut Pasteur, the CNRS and Sanofi Pasteur have recently developed a novel alternative method to animal testing that can be used to verify the safety of vaccines such as the yellow fever vaccine.

READ MORE

Sartorius Stedim Biotech and Siemens Sign Automation Agreement

News

Siemens becomes a preferred supplier for automation solutions. Product portfolio of Sartorius Stedim Biotech to feature a globally standardized automation platform in the future.

READ MORE

Vaccine Based on Spider Silk

News

By successfully encapsulating a vaccine into a spider silk microparticle researchers have discovered a novel technique that will help fight cancer and certain infectious diseases.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy